A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2017; you can also visit the original URL.
The file type is application/pdf
.
An approach to identify new antihypertensive agents using Thermolysin as model: In silico study based on QSARINS and docking
2016
Arabian Journal of Chemistry
Thermolysin is a bacterial proteolytic enzyme, considered by many authors as a pharmacological and biological model of other mammalian enzymes, with similar structural characteristics, such as angiotensin converting enzyme and neutral endopeptidase. Inhibitors of these enzymes are considered therapeutic targets for common diseases, such as hypertension and heart failure. In this report, a mathematical model of Multiple Linear Regression, for ordinary least squares, and genetic algorithm, for
doi:10.1016/j.arabjc.2016.10.003
fatcat:sfno7d5ybvc3nhamajsllczfc4